Directori de persones
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Grau: Doctor/a

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Publicacions

  • Felip, I; Moiola, CP; Megino-Luque, C; Lopez-Gil, C; Cabrera, S; Sole-Sanchez, S; Muñoz-Guardiola P; Megias-Roda, E; Perez-Montoyo, H; Alfon, J; Yeste-Velasco, M; Santacana, M; Dolcet, X; Reques, A; Oaknin, A; Rodriguez-Freixinos, V; Lizcano, JM; Domènech C; Gil-Moreno, A; Matias-Guiu, X; Colas, E; Eritja, N

    Therapeutic potential of the new TRIB3-mediated cell autophagy anticancer drug ABTL0812 in endometrial cancer

    Gynecologic Oncology 153 425-435. .

    [doi:10.1016/j.ygyno.2019.03.002]

  • Karpathiou, G; Matias-Guiu, X; Mobarki, M; Vermesch, C; Stachowicz, ML; Chauleur, Celine; Peoc'h, M

    Ovarian neuroendocrine carcinoma of metastatic origin: clues for diagnosis

    HUMAN PATHOLOGY 85 309-312. .

    [doi:10.1016/j.humpath.2018.08.015]

  • Mariscal, J; Fernandez-Puente, P; Calamia, V; Abalo, A; Santacana, M; Matias-Guiu, X; Lopez-Lopez, R; Gil-Moreno, A; Alonso-Alconada, L; Abal, M

    Proteomic Characterization of Epithelial-Like Extracellular Vesicles in Advanced Endometrial Cancer

    JOURNAL OF PROTEOME RESEARCH 18 1043-1053. .

    [doi:10.1021/acs.jproteome.8b00750]

  • MATIAS-GUIU GUIA, XAVIER; Condom, Enric

    Similarities and Differences in Neuroendocrine Tumors of the Male and Female Genital Tracts and Urinary Tract

    Gynecologic and Urologic Pathology: Similarities, Differences and Challenges 233-244. .

    [doi:10.1017/9781316756423.022]

  • Georgouli, M; Herraiz, C; Crosas-Molist, E; Fanshawe, B; Maiques, O; Perdrix, A; Pandya, P; Rodriguez-Hernandez, I; Ilieva, KM; Cantelli, G; Karagiannis, P; Mele, S; Lam, H; Josephs, DH; Matias-Guiu, X; Marti, RM; Nestle, FO; Orgaz, JL; Malanchi, I; Fruhwirth, GO; Karagiannis, SN; Sanz-Moreno, V

    Regional Activation of Myosin II in Cancer Cells Drives Tumor Progression via a Secretory Cross-Talk with the Immune Microenvironment

    CELL 176 757-77423. .

    [doi:10.1016/j.cell.2018.12.038]

  • del Rosario Taco Sanchez, Maria; Soler-Monso, T; Petit, A; Azcarate, J; Lasheras, A; Artal, C; Gil, M; Falo, C; Pla, MJ; Matias-Guiu, X

    Digital quantification of KI-67 in breast cancer

    VIRCHOWS ARCHIV 474 169-176. .

    [doi:10.1007/s00428-018-2481-3]

  • Stewart CJR; Crum, CP; McCluggage, WG; Park, KJ; Rutgers, JK; Oliva, E; Malpica, A; Parkash, V; Matias-Guiu, X; Ronnett, BM

    Guidelines to Aid in the Distinction of Endometrial and Endocervical Carcinomas, and the Distinction of Independent Primary Carcinomas of the Endometrium and Adnexa From Metastatic Spread Between These and Other Sites

    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 38 75-92. .

    [doi:10.1097/PGP.0000000000000553]

  • Cho, KR; Cooper, K; Croce, S; Djordevic, B; Herrington, S; Howitt, B; Hui, P; Ip, P; Koebel, M; Lax, S; Quade, BJ; Shaw, P; Vidal, A; Yemelyanova, A; Clarke, B; Hedrick Ellenson L; Longacre, TA; Shih, IM; McCluggage, WG; Malpica, A; Oliva, E; Parkash, V; Matias-Guiu, X

    International Society of Gynecological Pathologists (ISGyP) Endometrial Cancer Project: Guidelines From the Special Techniques and Ancillary Studies Group

    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 38 114-122. .

    [doi:10.1097/PGP.0000000000000496]

  • Dosil, MA; Navaridas, R; Mirantes, C; Tarragona, J; Eritja, N; Felip, I; Urdanibia, I; Megino, C; Domingo, M; Santacana, M; Gatius, S; Piñol C; Barcelo, C; Maiques, O; Macia, A; Velasco, A; Vaquero, M; Matias-Guiu, X; Dolcet, X

    Tumor suppressive function of E2F-1 on PTEN-induced serrated colorectal carcinogenesis

    JOURNAL OF PATHOLOGY 247 72-85. .

    [doi:10.1002/path.5168]

  • Matias-Guiu, Xavier; Fuste, Victoria; Iglesias, Lara; Balañá C.; Concha, Angel; de la Cruz-Merino, Luis; Nieto, Beatriz; Pane, Maria; Sanz, Julian; Losa, Ferran

    Consenso 2018 de la Sociedad Española de Anatomía Patológica y la Sociedad Española de Oncología Médica sobre el diagnóstico y tratamiento del cáncer de origen desconocido.

    Revista Espanola de Patologia 52 33-44. .

    [doi:10.1016/j.patol.2018.08.002]

  • Rabban, JT; Gilks, CB; Malpica, A; Matias-Guiu, X; Mittal, K; Mutter, GL; Oliva, E; Parkash, V; Ronnett, BM; Staats, P; Stewart CJR; McCluggage, WG

    Issues in the Differential Diagnosis of Uterine Low-grade Endometrioid Carcinoma, Including Mixed Endometrial Carcinomas: Recommendations from the International Society of Gynecological Pathologists

    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 38 25-39. .

    [doi:10.1097/PGP.0000000000000512]

  • McCluggage, WG; Malpica, A; Matias-Guiu, X; Oliva, E; Parkash, V

    The International Society of Gynecological Pathologists (ISGyP) Endometrial Carcinoma Project

    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 38 1-2. .

    [doi:10.1097/PGP.0000000000000495]

Projectes

  • Unravelling the molecular and phenotypic complexity of endometriosis through new models and omics integration: towards a personalized clinical management
  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EPH Receptor Signaling in Endometrial Cancer
  • Ajuts per a la contractació de personal investigador novell (FI)
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU